Juno Therapeutics, the Seattle-based clinical cancer research firm is doing groundbreaking work in seeking a cure for the disease. CEO Hans Bishop said at the GeekWire Summit on Tuesday that the biotech company’s original name gets at the heart of it all.
Juno was originally called FC Therapeutics, Bishop told GeekWire.
So what did FC stand for?
“First, the F is a four-letter Anglo-Saxon word,” Bishop said. “The second word is cancer.”
